Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Trehalose: Detailed Review on its Transformative R&D Success, Mechanism of Action, and Drug Targets
Drug Insights
4 min read
Trehalose: Detailed Review on its Transformative R&D Success, Mechanism of Action, and Drug Targets
30 August 2023
This article summarized the latest R&D progress of Trehalose, the Mechanism of Action for Trehalose, and the drug target for Trehalose.
Read →
AbbVie has lodged filings with the FDA and EMA for approval of Risankizumab (SKYRIZI®) to treat Ulcerative Colitis
Latest Hotspot
5 min read
AbbVie has lodged filings with the FDA and EMA for approval of Risankizumab (SKYRIZI®) to treat Ulcerative Colitis
30 August 2023
This IL-23 inhibitor, risankizumab, is being tested as a potential remedy for adults suffering from moderately to severely active ulcerative colitis.
Read →
An In-depth Analysis of Ropinirole's R&D Progress and Mechanism of Action on Drug Targets
Drug Insights
5 min read
An In-depth Analysis of Ropinirole's R&D Progress and Mechanism of Action on Drug Targets
30 August 2023
This article summarized the latest R&D progress of Ropinirole, Mechanism of Action for Ropinirole and drug target for Ropinirole.
Read →
The primary objective of BlueRock's Phase I trial involving bemdaneprocel for individuals suffering from Parkinson's disease has been successfully achieved
Latest Hotspot
6 min read
The primary objective of BlueRock's Phase I trial involving bemdaneprocel for individuals suffering from Parkinson's disease has been successfully achieved
30 August 2023
The investigational cell treatment, bemdaneprocel (BRT-DA01), showed good tolerance and no major safety concerns throughout a year in 12 subjects belonging to both low and high dose groups.
Read →
Investigating the Potential Functionality and Global Development Status of Unknown Sequences
Bio Sequence
2 min read
Investigating the Potential Functionality and Global Development Status of Unknown Sequences
30 August 2023
During the course of scientific research and the development process, researchers may often be confronted with unknown functional sequences. The recommended approach, prior to traditional experimental testing, is to explore their potential functionality and applicability by searching for analogous sequences and relevant patent data in established databases.
Read →
Merck Initiates Phase 3 Clinical trial for PCSK9 Inhibitor MK-0616
Latest Hotspot
4 min read
Merck Initiates Phase 3 Clinical trial for PCSK9 Inhibitor MK-0616
29 August 2023
Merck has today made public the launch of the company's Phase 3 clinical trials, labeled as CORALreef, for MK-0616, a potential oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.
Read →
Easily Obtain Gene Sequences by Using Gene Names in The Patsnap Bio Database
Bio Sequence
3 min read
Easily Obtain Gene Sequences by Using Gene Names in The Patsnap Bio Database
29 August 2023
Acquiring the sequence of a gene founded on its title is feasible and this article introduces one uncomplicated and swift technique that is consistently utilized.
Read →
How does AstraZeneca's PARP inhibitor differentiate?
Valuable Targets
10 min read
How does AstraZeneca's PARP inhibitor differentiate?
28 August 2023
PARP inhibitors had once brought about a "decade breakthrough" for ovarian cancer, and in search for new areas of business growth, AZ is primarily seeking the approval for the use of olaparib in metastatic prostate cancer.
Read →
Can Arvinas lead the treatment of neurodegenerative diseases?
Advanced Tech.
8 min read
Can Arvinas lead the treatment of neurodegenerative diseases?
25 August 2023
Arvinas is currently conducting preclinical studies on protein degradation for neurodegenerative diseases.
Read →
The world's first Maternal Vaccine! Analysis of Pfizer's RSV Vaccine
Drug Insights
3 min read
The world's first Maternal Vaccine! Analysis of Pfizer's RSV Vaccine
25 August 2023
This is the first and only RSV vaccine for pregnant women, marking an important milestone for public health.
Read →
Sales fall short of expectations, how can KRAS G12C be differentiated in R&D?
Valuable Targets
10 min read
Sales fall short of expectations, how can KRAS G12C be differentiated in R&D?
25 August 2023
With KRAS, a previously considered untouchable target, being cracked open, the KRAS G12C inhibitors of Amgen and Mirati are now on the market. The question is, how can we further optimize treatment outcomes for patients?
Read →
Variation Report — A Valuable Tool for Investigating Sequence Mutations within Drug Development
Bio Sequence
3 min read
Variation Report — A Valuable Tool for Investigating Sequence Mutations within Drug Development
24 August 2023
Adeno-associated virus (AAV) is reckoned as one of the most propitious vectors for gene research and therapy. It is recommended to use the Patsnap Bio sequence database to extract sequences analogous to definite AAV sequences and examine new AAV data from sources accessible to the public, thereby providing a catalyst for advanced AAV research.
Read →